Adiponectin, C1Q and Collagen Domain Containing (ADIPOQ) (AA 55-69,N-Term) antibody
| Antigen | Adiponectin, C1Q and Collagen Domain Containing (ADIPOQ) |
| Synonyms | ACDC, ADPN, APM1, APM-1, GBP28, ACRP30, ADIPQTL1, adiponectin, APN, Acdc, apM1, 30kDa, adipo, Acrp30, ADIPOQ, MGC138982, ADN, MGC84292 |
| Binding Site |
Alternatives AA 55-69,N-Term |
| Clonality | Polyclonal |
| Host |
Alternatives Rabbit |
| Reactivity |
Alternatives Human, Mouse (Murine) |
| Conjugate |
Alternatives Un-conjugated |
| Application |
Alternatives Immunohistochemistry (IHC) |
![]() |
6 references available |
| Catalog no. | ABIN965514 |
| Quantity | 0.1mg |
| Price | 316.25 $ Plus shipping costs $45.00 |
| Shipping to |
|
| Availability | Will be delivered in 5 to 7 Business Days |
Additional Information
| Alternative name | ADIPOQ |
| Immunogen | Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to residues 55-69 of human ADIPOQ(Adiponectin precursor) |
| Description | ADIPOQ (Adiponectin) is an important negative regulator in hematopoiesis and immunesystems. ADIPOQ may be involved in ending inflammatory responses through its inhibitory functions. ADIPOQ inhibits endothelial NF-kappa-B signaling through a cAMP-dependent pathway. It inhibits TNF-alpha-induced expression of endothelial adhesion molecules. ADIPOQ is involved in the control of fat metabolism and insulin sensitivity. Defects in ADIPOQ are the cause of adiponectin deficiency. The result is a very low concentration of plasma adiponectin. The decreased adiponectin plasma levels are associated with obesity insulin resistance, and diabetes type 2. |
Application Details
| Application Notes | ELISA, Western blotting: 1µg/ml for 2hrs. |
| Purification | Purified by antigen-specific affinity chromatography. |
| Buffer | This antibody is stored in PBS, 50% glycerol |
| Preservative | 0.01% Sodium Azide |
| Storage | Store at -20°C. |
| Restrictions | For Research Use only |
Publications
| Product |
Nakano, Tobe, Choi-Miura et al.: "Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma." in: Journal of biochemistry, Vol. 120, Issue 4, pp. 803-12, 1997 (PubMed).
Arita, Kihara, Ouchi et al.: "Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity." in: Biochemical and biophysical research communications, Vol. 257, Issue 1, pp. 79-83, 1999 (PubMed). Saito, Tobe, Minoshima et al.: "Organization of the gene for gelatin-binding protein (GBP28)." in: Gene, Vol. 229, Issue 1-2, pp. 67-73, 1999 (PubMed). Schäffler, Orsó, Palitzsch et al.: "The human apM-1, an adipocyte-specific gene linked to the family of TNF's and to genes expressed in activated T cells, is mapped to chromosome 1q21.3-q23, a susceptibility locus identified for familial combined hyperlipidaemia (FCH)." in: Biochemical and biophysical research communications, Vol. 260, Issue 2, pp. 416-25, 1999 (PubMed). Yokota, Oritani, Takahashi et al.: "Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages." in: Blood, Vol. 96, Issue 5, pp. 1723-32, 2000 (PubMed). Ouchi, Kihara, Arita et al.: "Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway." in: Circulation, Vol. 102, Issue 11, pp. 1296-301, 2000 (PubMed). |
Alternatives
Alternatives for antigen "Adiponectin, C1Q and Collagen Domain Containing (ADIPOQ)", type "Antibodies"




Alternatives